메뉴 건너뛰기




Volumn 118, Issue 3, 2012, Pages 660-669

A nomogram to predict postresection 5-year overall survival for patients with uterine leiomyosarcoma

Author keywords

nomogram; prognosis; staging; survival; uterine leiomyosarcoma

Indexed keywords

ANTINEOPLASTIC AGENT;

EID: 84856208980     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26333     Document Type: Article
Times cited : (134)

References (43)
  • 2
    • 0025281007 scopus 로고
    • Treatment of uterine sarcomas
    • Echt G, Jepson J, Steel J, et al. Treatment of uterine sarcomas. Cancer. 1990; 66: 35-39.
    • (1990) Cancer. , vol.66 , pp. 35-39
    • Echt, G.1    Jepson, J.2    Steel, J.3
  • 3
    • 0024557084 scopus 로고
    • Patterns of metastasis in uterine sarcoma. An autopsy study
    • Rose PG, Piver MS, Tsukada Y, Lau T,. Patterns of metastasis in uterine sarcoma. An autopsy study. Cancer. 1989; 63: 935-938.
    • (1989) Cancer. , vol.63 , pp. 935-938
    • Rose, P.G.1    Piver, M.S.2    Tsukada, Y.3    Lau, T.4
  • 4
    • 38549166650 scopus 로고    scopus 로고
    • Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths
    • Ueda SM, Kapp DS, Cheung MK, et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol. 2008; 198: 218.e1-218.e6.
    • (2008) Am J Obstet Gynecol. , vol.198
    • Ueda, S.M.1    Kapp, D.S.2    Cheung, M.K.3
  • 5
    • 65349159791 scopus 로고    scopus 로고
    • Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer staging systems
    • Zivanovic O, Leitao MM, Iasonos A, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer staging systems. J Clin Oncol. 2009; 27: 2066-2072.
    • (2009) J Clin Oncol. , vol.27 , pp. 2066-2072
    • Zivanovic, O.1    Leitao, M.M.2    Iasonos, A.3
  • 6
    • 0141645574 scopus 로고    scopus 로고
    • Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus
    • Leitao MM, Sonoda Y, Brennan MF, Barakat RR, Chi DS,. Incidence of lymph node and ovarian metastases in leiomyosarcoma of the uterus. Gynecol Oncol. 2003; 91: 209-212.
    • (2003) Gynecol Oncol. , vol.91 , pp. 209-212
    • Leitao, M.M.1    Sonoda, Y.2    Brennan, M.F.3    Barakat, R.R.4    Chi, D.S.5
  • 7
    • 0022006615 scopus 로고
    • A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: A Gynecologic Oncology Group study
    • Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant Adriamycin in uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol. 1985; 3: 1240-1245.
    • (1985) J Clin Oncol. , vol.3 , pp. 1240-1245
    • Omura, G.A.1    Blessing, J.A.2    Major, F.3
  • 8
    • 41849100978 scopus 로고    scopus 로고
    • European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages i and II: A European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874)
    • Reed NS, Mangioni C, Malmstrom H, et al. European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: a European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group study (protocol 55874). Eur J Cancer. 2008; 44: 808-818.
    • (2008) Eur J Cancer. , vol.44 , pp. 808-818
    • Reed, N.S.1    Mangioni, C.2    Malmstrom, H.3
  • 10
    • 45849107274 scopus 로고    scopus 로고
    • Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas
    • Sorbe B, Johansson B,. Prophylactic pelvic irradiation as part of primary therapy in uterine sarcomas. Int J Oncol. 2008; 32: 1111-1117.
    • (2008) Int J Oncol. , vol.32 , pp. 1111-1117
    • Sorbe, B.1    Johansson, B.2
  • 12
    • 70350008454 scopus 로고    scopus 로고
    • Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma
    • Raut CP, Nucci MR, Wang Q, et al. Predictive value of FIGO and AJCC staging systems in patients with uterine leiomyosarcoma. Eur J Cancer. 2009; 45: 2818-2824.
    • (2009) Eur J Cancer. , vol.45 , pp. 2818-2824
    • Raut, C.P.1    Nucci, M.R.2    Wang, Q.3
  • 13
    • 66549090700 scopus 로고    scopus 로고
    • FIGO staging for uterine sarcomas
    • Prat J,. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet. 2009; 104: 177-178.
    • (2009) Int J Gynaecol Obstet. , vol.104 , pp. 177-178
    • Prat, J.1
  • 14
    • 68149162597 scopus 로고    scopus 로고
    • Prognostic factors in early stage leiomyosarcoma of the uterus
    • Pelmus M, Penault-Llorca F, Guillou L, et al. Prognostic factors in early stage leiomyosarcoma of the uterus. Int J Gynecol Cancer. 2009; 19: 385-390.
    • (2009) Int J Gynecol Cancer. , vol.19 , pp. 385-390
    • Pelmus, M.1    Penault-Llorca, F.2    Guillou, L.3
  • 15
    • 60349124586 scopus 로고    scopus 로고
    • Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients
    • Abeler VM, Royne O, Thoresen S, Danielsen HE, Nesland JM, Kristensen GB,. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology. 2009; 54: 355-364.
    • (2009) Histopathology. , vol.54 , pp. 355-364
    • Abeler, V.M.1    Royne, O.2    Thoresen, S.3    Danielsen, H.E.4    Nesland, J.M.5    Kristensen, G.B.6
  • 16
    • 0842332132 scopus 로고    scopus 로고
    • The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital
    • Dinh TA, Oliva EA, Fuller AF Jr, Lee H, Goodman A,. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital. Gynecol Oncol. 2004; 92: 648-652.
    • (2004) Gynecol Oncol. , vol.92 , pp. 648-652
    • Dinh, T.A.1    Oliva, E.A.2    Fuller Jr., A.F.3    Lee, H.4    Goodman, A.5
  • 17
    • 0032771172 scopus 로고    scopus 로고
    • Leiomyosarcoma of the uterus: A clinicopathologic multicenter study of 71 cases
    • Mayerhofer K, Obermair A, Windbichler G, et al. Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol. 1999; 74: 196-201.
    • (1999) Gynecol Oncol. , vol.74 , pp. 196-201
    • Mayerhofer, K.1    Obermair, A.2    Windbichler, G.3
  • 18
    • 0023898196 scopus 로고
    • The role of the pathologist in the management of soft tissue sarcomas
    • Hajdu SI, Shiu MH, Brennan MF,. The role of the pathologist in the management of soft tissue sarcomas. World J Surg. 1988; 12: 326-331.
    • (1988) World J Surg. , vol.12 , pp. 326-331
    • Hajdu, S.I.1    Shiu, M.H.2    Brennan, M.F.3
  • 19
    • 0028335176 scopus 로고
    • Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases
    • Bell SW, Kempson RL, Hendrickson MR,. Problematic uterine smooth muscle neoplasms. A clinicopathologic study of 213 cases. Am J Surg Pathol. 1994; 18: 535-558.
    • (1994) Am J Surg Pathol. , vol.18 , pp. 535-558
    • Bell, S.W.1    Kempson, R.L.2    Hendrickson, M.R.3
  • 20
    • 41549166181 scopus 로고    scopus 로고
    • Uterine mesenchymal tumors: A review of selected topics
    • Soslow RA,. Uterine mesenchymal tumors: a review of selected topics. Diagn Histopathol. 2008; 14: 175-188.
    • (2008) Diagn Histopathol. , vol.14 , pp. 175-188
    • Soslow, R.A.1
  • 21
    • 37348999883 scopus 로고    scopus 로고
    • Diagnostic criteria for uterine smooth muscle tumors: Leiomyoma variants associated with malignant behavior
    • Giuntoli RL second, Gostout BS, DiMarco CS, Metzinger DS, Keeney GL,. Diagnostic criteria for uterine smooth muscle tumors: leiomyoma variants associated with malignant behavior. J Reprod Med. 2007; 52: 1001-1010.
    • (2007) J Reprod Med. , vol.52 , pp. 1001-1010
    • Giuntoli Second, R.L.1    Gostout, B.S.2    Dimarco, C.S.3    Metzinger, D.S.4    Keeney, G.L.5
  • 22
    • 44449135941 scopus 로고    scopus 로고
    • Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II study
    • Hensley ML, Blessing JA, Degeest K, Abulafia O, Rose PG, Homesley HD,. Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study. Gynecol Oncol. 2008; 109: 323-328.
    • (2008) Gynecol Oncol. , vol.109 , pp. 323-328
    • Hensley, M.L.1    Blessing, J.A.2    Degeest, K.3    Abulafia, O.4    Rose, P.G.5    Homesley, H.D.6
  • 23
    • 44449096592 scopus 로고    scopus 로고
    • Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
    • Hensley ML, Blessing JA, Mannel R, Rose PG,. Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol. 2008; 109: 329-334.
    • (2008) Gynecol Oncol. , vol.109 , pp. 329-334
    • Hensley, M.L.1    Blessing, J.A.2    Mannel, R.3    Rose, P.G.4
  • 24
    • 60449099927 scopus 로고    scopus 로고
    • Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study
    • Hensley ML, Ishill N, Soslow R, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol. 2009; 112: 563-567.
    • (2009) Gynecol Oncol. , vol.112 , pp. 563-567
    • Hensley, M.L.1    Ishill, N.2    Soslow, R.3
  • 25
    • 0037096747 scopus 로고    scopus 로고
    • Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: Results of a phase II trial
    • Hensley ML, Maki R, Venkatraman E, et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol. 2002; 20: 2824-2831.
    • (2002) J Clin Oncol. , vol.20 , pp. 2824-2831
    • Hensley, M.L.1    Maki, R.2    Venkatraman, E.3
  • 26
    • 34447572873 scopus 로고    scopus 로고
    • Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: Results of Sarcoma Alliance for Research Through Collaboration study 002 [corrected]
    • Maki RG, Wathen JK, Patel SR, et al. Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of Sarcoma Alliance for Research Through Collaboration study 002 [corrected]. J Clin Oncol. 2007; 25: 2755-2763.
    • (2007) J Clin Oncol. , vol.25 , pp. 2755-2763
    • Maki, R.G.1    Wathen, J.K.2    Patel, S.R.3
  • 27
    • 41649106685 scopus 로고    scopus 로고
    • How to build and interpret a nomogram for cancer prognosis
    • Iasonos A, Schrag D, Raj GV, Panageas KS,. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008; 26: 1364-1370.
    • (2008) J Clin Oncol. , vol.26 , pp. 1364-1370
    • Iasonos, A.1    Schrag, D.2    Raj, G.V.3    Panageas, K.S.4
  • 28
    • 0030069896 scopus 로고    scopus 로고
    • Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors
    • Harrell FE Jr, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996; 15: 361-387.
    • (1996) Stat Med. , vol.15 , pp. 361-387
    • Harrell Jr., F.E.1    Lee, K.L.2    Mark, D.B.3
  • 29
    • 0037498554 scopus 로고    scopus 로고
    • Retrospective review of 208 patients with leiomyosarcoma of the uterus: Prognostic indicators, surgical management, and adjuvant therapy
    • Giuntoli RL, 2nd, Metzinger DS, DiMarco CS, et al. Retrospective review of 208 patients with leiomyosarcoma of the uterus: prognostic indicators, surgical management, and adjuvant therapy. Gynecol Oncol. 2003; 89: 460-469.
    • (2003) Gynecol Oncol. , vol.89 , pp. 460-469
    • Giuntoli II, R.L.1    Metzinger, D.S.2    Dimarco, C.S.3
  • 30
    • 39049114269 scopus 로고    scopus 로고
    • Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: Emphasis on impact of lymphadenectomy and oophorectomy
    • Kapp DS, Shin JY, Chan JK,. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008; 112: 820-830.
    • (2008) Cancer. , vol.112 , pp. 820-830
    • Kapp, D.S.1    Shin, J.Y.2    Chan, J.K.3
  • 31
    • 27944450863 scopus 로고    scopus 로고
    • Concordance probability and discriminatory power in proportional hazards regression
    • Gonen M, Heller G,. Concordance probability and discriminatory power in proportional hazards regression. Biometrika. 2005; 92: 965-970.
    • (2005) Biometrika. , vol.92 , pp. 965-970
    • Gonen, M.1    Heller, G.2
  • 32
    • 33748464977 scopus 로고    scopus 로고
    • Are nomograms better than currently available stage groupings for bladder cancer?
    • Sternberg CN,. Are nomograms better than currently available stage groupings for bladder cancer? J Clin Oncol. 2006; 24: 3819-3820.
    • (2006) J Clin Oncol. , vol.24 , pp. 3819-3820
    • Sternberg, C.N.1
  • 33
    • 0037336502 scopus 로고    scopus 로고
    • Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: Preoperative application in prostate cancer
    • Kattan MW,. Nomograms are superior to staging and risk grouping systems for identifying high-risk patients: preoperative application in prostate cancer. Curr Opin Urol. 2003; 13: 111-116.
    • (2003) Curr Opin Urol. , vol.13 , pp. 111-116
    • Kattan, M.W.1
  • 34
    • 38649125855 scopus 로고    scopus 로고
    • Individualized prediction of colon cancer recurrence using a nomogram
    • Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008; 26: 380-385.
    • (2008) J Clin Oncol. , vol.26 , pp. 380-385
    • Weiser, M.R.1    Landmann, R.G.2    Kattan, M.W.3
  • 35
    • 34548504813 scopus 로고    scopus 로고
    • A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
    • Walz J, Gallina A, Saad F, et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol. 2007; 25: 3576-3581.
    • (2007) J Clin Oncol. , vol.25 , pp. 3576-3581
    • Walz, J.1    Gallina, A.2    Saad, F.3
  • 36
    • 0036467991 scopus 로고    scopus 로고
    • Postoperative nomogram for 12-year sarcoma-specific death
    • Kattan MW, Leung DH, Brennan MF,. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002; 20: 791-796.
    • (2002) J Clin Oncol. , vol.20 , pp. 791-796
    • Kattan, M.W.1    Leung, D.H.2    Brennan, M.F.3
  • 37
    • 0347224331 scopus 로고    scopus 로고
    • Cancer and Leukemia Group B (CALGB) 90203: A randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease
    • Cancer and Leukemia Group B
    • Eastham JA, Kelly WK, Grossfeld GD, Small EJ,; Cancer and Leukemia Group B. Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease. Urology. 2003; 62 (suppl 1): 55-62.
    • (2003) Urology. , vol.62 , Issue.SUPPL. 1 , pp. 55-62
    • Eastham, J.A.1    Kelly, W.K.2    Grossfeld, G.D.3    Small, E.J.4
  • 38
    • 0032950295 scopus 로고    scopus 로고
    • Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer
    • Kattan MW, Wheeler TM, Scardino PT,. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999; 17: 1499-1507.
    • (1999) J Clin Oncol. , vol.17 , pp. 1499-1507
    • Kattan, M.W.1    Wheeler, T.M.2    Scardino, P.T.3
  • 39
    • 27244432751 scopus 로고    scopus 로고
    • Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    • Stephenson AJ, Scardino PT, Eastham JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol. 2005; 23: 7005-7012.
    • (2005) J Clin Oncol. , vol.23 , pp. 7005-7012
    • Stephenson, A.J.1    Scardino, P.T.2    Eastham, J.A.3
  • 40
    • 0142008434 scopus 로고    scopus 로고
    • Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    • Kattan MW, Karpeh MS, Mazumdar M, Brennan MF,. Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma. J Clin Oncol. 2003; 21: 3647-3650.
    • (2003) J Clin Oncol. , vol.21 , pp. 3647-3650
    • Kattan, M.W.1    Karpeh, M.S.2    Mazumdar, M.3    Brennan, M.F.4
  • 41
    • 3242671534 scopus 로고    scopus 로고
    • Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
    • Brennan MF, Kattan MW, Klimstra D, Conlon K,. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004; 240: 293-298.
    • (2004) Ann Surg. , vol.240 , pp. 293-298
    • Brennan, M.F.1    Kattan, M.W.2    Klimstra, D.3    Conlon, K.4
  • 42
    • 0035819891 scopus 로고    scopus 로고
    • Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention
    • Rockhill B, Spiegelman D, Byrne C, Hunter DJ, Colditz GA,. Validation of the Gail et al model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst. 2001; 93: 358-366.
    • (2001) J Natl Cancer Inst. , vol.93 , pp. 358-366
    • Rockhill, B.1    Spiegelman, D.2    Byrne, C.3    Hunter, D.J.4    Colditz, G.A.5
  • 43
    • 4444252760 scopus 로고    scopus 로고
    • Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma
    • Leitao MM, Soslow RA, Nonaka D, et al. Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma. Cancer. 2004; 101: 1455-1462.
    • (2004) Cancer. , vol.101 , pp. 1455-1462
    • Leitao, M.M.1    Soslow, R.A.2    Nonaka, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.